Pentwater Capital Management’s Genmab GMAB Stock Holding History

Pentwater Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$328K	–	329
2021 Q1	$328K	Hold	10,000	–	–	﹤0.01%	311
2020 Q4	$407K	Hold	10,000	–	–	﹤0.01%	207
2020 Q3	$366K	Sell	10,000 -10,000	-50%	-$362K	﹤0.01%	195
2020 Q2	$678K	Sell	20,000 -6,420	-24%	-$175K	0.01%	118
2020 Q1	$560K	Sell	26,420 -8,580	-25%	-$191K	0.01%	101
2019 Q4	$782K	Sell	35,000 -1,500	-4%	-$32.7K	0.01%	112
2019 Q3	$739K	Buy	+36,500	New	+$719K	0.01%	118

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Pentwater Capital Management's GMAB Position: Q2 2021 in Review

Pentwater Capital Management sold out of Genmab (GMAB) in Q2 2021, closing a stake of 10,000 shares — an estimated $328K sold.

Pentwater Capital Management first reported a position in GMAB in Q3 2019 and held it in 7 quarters. The position peaked at $782K in Q4 2019. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

Pentwater Capital Management reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
Pentwater Capital Management sold 10,000 Genmab shares in Q2 2021, an estimated $328K.
Pentwater Capital Management first reported a position in Genmab in Q3 2019 and held it in 7 quarters.
Pentwater Capital Management's Genmab position peaked at $782K in Q4 2019.
212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.